Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2578)
All Articles published online
|
Sep 1, 2004 (publication date) through Nov 5, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang XJ, Yuan SL, Lu Q, Lu YR, Zhang J, Liu Y, Wang WD. Potential involvement of leptin in carcinogenesis of hepatocellular carcinoma. World J Gastroenterol 2004; 10(17): 2478-2481 [PMID: 15300888 DOI: 10.3748/wjg.v10.i17.2478] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v10/i17/2478.htm |
| Number | Citing Articles |
| 1 |
Taesung Park, Sung-Gon Yi, Young Kee Shin, SeungYeoun Lee. Combining multiple microarrays in the presence of controlling variables. Bioinformatics 2006; 22(14): 1682 doi: 10.1093/bioinformatics/btl183
|
| 2 |
Muhammad Ihtisham Umar, Waseem Hassan, Ghulam Murtaza, Manal Buabeid, Elshaimaa Arafa, Hafiz Muhammad Irfan, Mohd Zaini Asmawi, Xianju Huang. The Adipokine Component in the Molecular Regulation of Cancer Cell Survival, Proliferation and Metastasis. Pathology and Oncology Research 2021; 27 doi: 10.3389/pore.2021.1609828
|
| 3 |
Jing Zhou, Wei Lei, Lei Shen, He-Sheng Luo, Zhi-Xiang Shen. Primary study of leptin and human hepatocellular carcinoma <italic>in vitro</italic>. World Journal of Gastroenterology 2008; 14(18): 2900-2904 doi: 10.3748/wjg.14.2900
|
| 4 |
Seo Yeon Lee, Se Jun Park, In Ho Jang, Soon Chul Myung, Tae Hyoung Kim. The Effects of Adiponectin and Leptin in the Proliferation of Prostate Cancer Cells. Korean Journal of Urology 2009; 50(5): 493 doi: 10.4111/kju.2009.50.5.493
|
| 5 |
S-N Wang, S-C Chuang, Y-T Yeh, S-F Yang, C-Y Chai, W-T Chen, K-K Kuo, J-S Chen, K-T Lee. Potential prognostic value of leptin receptor in hepatocellular carcinoma. Journal of Clinical Pathology 2006; 59(12): 1267 doi: 10.1136/jcp.2005.033464
|
| 6 |
Renxiong Wei, Yaoren Hu, Feibo Dong, Xiaozhen Xu, Airong Hu, Guosheng Gao. Hepatoma cell‐derived leptin downregulates the immunosuppressive function of regulatory T‐cells to enhance the anti‐tumor activity of CD8+ T‐cells. Immunology & Cell Biology 2016; 94(4): 388 doi: 10.1038/icb.2015.110
|
| 7 |
Shiye Yang, Haishun Ni, Aixian Zhang, Jixiang Zhang, Huoqi Liang, Xing Li, Jiayi Qian, Hong Zang, Zhibing Ming. Body mass index is a risk factor for postoperative morbidity after laparoscopic hepatectomy of hepatocellular carcinoma: a multicenter retrospective study. Journal of Cancer Research and Clinical Oncology 2024; 150(10) doi: 10.1007/s00432-024-05979-w
|
| 8 |
Lisa P. Weeth, Andrea J. Fascetti, Philip H. Kass, Steven E. Suter, Aniel M. Santos, Sean J. Delaney. Prevalence of obese dogs in a population of dogs with cancer. American Journal of Veterinary Research 2007; 68(4): 389 doi: 10.2460/ajvr.68.4.389
|
| 9 |
Tohru Utsunomiya, Masahiro Okamoto, Toshihumi Kameyama, Ayumi Matsuyama, Manabu Yamamoto, Megumu Fujiwara, Masaki Mori, Shiomi Aimitsu, Teruyoshi Ishida. Impact of obesity on the surgical outcome following repeat hepatic resection in Japanese patients with recurrent hepatocellular carcinoma. World Journal of Gastroenterology 2008; 14(10): 1553-1558 doi: 10.3748/wjg.14.1553
|
| 10 |
Eran Elinav, Asad Abd-Elnabi, Orit Pappo, Itamar Bernstein, Athalia Klein, Dean Engelhardt, Elazar Rabbani, Yaron Ilan. Suppression of hepatocellular carcinoma growth in mice via leptin, is associated with inhibition of tumor cell growth and natural killer cell activation. Journal of Hepatology 2006; 44(3): 529 doi: 10.1016/j.jhep.2005.08.013
|
| 11 |
Shih-Ping Cheng, Chin-Wen Chi, Chi-Yuan Tzen, Tsen-Long Yang, Jie-Jen Lee, Tsang-Pai Liu, Chien-Liang Liu. Clinicopathologic significance of leptin and leptin receptor expressions in papillary thyroid carcinoma. Surgery 2010; 147(6): 847 doi: 10.1016/j.surg.2009.11.004
|
| 12 |
Xiao-Feng Duan, Peng Tang, Qiang Li, Zhen-Tao Yu. Obesity, adipokines and hepatocellular carcinoma. International Journal of Cancer 2013; 133(8): 1776 doi: 10.1002/ijc.28105
|
| 13 |
Asma Siddique, Kris V. Kowdley. Insulin Resistance and Other Metabolic Risk Factors in the Pathogenesis of Hepatocellular Carcinoma. Clinics in Liver Disease 2011; 15(2): 281 doi: 10.1016/j.cld.2011.03.007
|
| 14 |
Jiong-Jie Yu, Lei Liang, Lun Lu, Chao Li, Hao Xing, Wan-Guang Zhang, Xian-Hai Mao, Yong-Yi Zeng, Ting-Hao Chen, Ya-Hao Zhou, Hong Wang, Timothy M. Pawlik, Han Wu, Wan Yee Lau, Meng-Chao Wu, Feng Shen, Tian Yang. Association between body mass index and postoperative morbidity after liver resection of hepatocellular carcinoma. HPB 2020; 22(2): 289 doi: 10.1016/j.hpb.2019.06.021
|
| 15 |
Vairappan Balasubramaniyan, Ruchi Shukla, Gopal Murugaiyan, Ramchandra Ramesh Bhonde, Namasivayam Nalini. Mouse recombinant leptin protects human hepatoma HepG2 against apoptosis, TNF-α response and oxidative stress induced by the hepatotoxin–ethanol. Biochimica et Biophysica Acta (BBA) - General Subjects 2007; 1770(8): 1136 doi: 10.1016/j.bbagen.2007.04.009
|
| 16 |
Domenico Ribatti, Anna Sandra Belloni, Beatrice Nico, Mariasevera Di Comite, Enrico Crivellato, Angelo Vacca. Leptin–leptin receptor are involved in angiogenesis in human hepatocellular carcinoma. Peptides 2008; 29(9): 1596 doi: 10.1016/j.peptides.2008.05.011
|
| 17 |
Shahrzad Amiri Darban, Sara Nikoofal-Sahlabadi, Nafise Amiri, Nafiseh Kiamanesh, Amin Mehrabian, Bamdad Zendehbad, Zahra Gholizadeh, Mahmoud Reza Jaafari. Targeting the leptin receptor: To evaluate therapeutic efficacy and anti-tumor effects of Doxil, in vitro and in vivo in mice bearing C26 colon carcinoma tumor. Colloids and Surfaces B: Biointerfaces 2018; 164: 107 doi: 10.1016/j.colsurfb.2018.01.035
|
| 18 |
N A H Sadik, A Ahmed, S Ahmed. The significance of serum levels of adiponectin, leptin, and hyaluronic acid in hepatocellular carcinoma of cirrhotic and noncirrhotic patients. Human & Experimental Toxicology 2012; 31(4): 311 doi: 10.1177/0960327111431091
|
| 19 |
Lisa P. Weeth. Other Risks/Possible Benefits of Obesity. Veterinary Clinics of North America: Small Animal Practice 2016; 46(5): 843 doi: 10.1016/j.cvsm.2016.04.007
|
| 20 |
|
| 21 |
Yu Saito, Yuji Morine, Tetsuya Ikemoto, Shinichiro Yamada, Hiroki Teraoku, Sonoko Yasui‐Yamada, Maki Nishi, Hiroshi Sakaue, Motomu Kamada, Tetsuya Matsuura, Mitsuo Shimada. Preoperative Weight Loss Program for Hepatocellular Carcinoma Patients with High Body Mass Index in Hepatectomy. World Journal of Surgery 2023; 47(12): 3348 doi: 10.1007/s00268-023-07220-0
|
| 22 |
Mazen Noureddin, Mary E. Rinella. Nonalcoholic Fatty Liver Disease, Diabetes, Obesity, and Hepatocellular Carcinoma. Clinics in Liver Disease 2015; 19(2): 361 doi: 10.1016/j.cld.2015.01.012
|
| 23 |
Ya-Ling Lee, Wan-Chun Li, Tung-Hu Tsai, Hsin-Yu Chiang, Chin-Tsung Ting. Body mass index and cholesterol level predict surgical outcome in patients with hepatocellular carcinoma in Taiwan - a cohort study. Oncotarget 2016; 7(16): 22948 doi: 10.18632/oncotarget.8312
|
| 24 |
Mitsuteru Kitade, Hitoshi Yoshiji, Hideyuki Kojima, Yasuhide Ikenaka, Ryuichi Noguchi, Kosuke Kaji, Junichi Yoshii, Koji Yanase, Tadashi Namisaki, Kiyoshi Asada, Masaharu Yamazaki, Tatsuhiro Tsujimoto, Takemi Akahane, Masahito Uemura, Hiroshi Fukui. Leptin‐mediated neovascularization is a prerequisite for progression of nonalcoholic steatohepatitis in rats†. Hepatology 2006; 44(4): 983 doi: 10.1002/hep.21338
|
| 25 |
Laura C. Schulz, Eric P. Widmaier. Leptin. Endocrine Updates 2006; 25: 11 doi: 10.1007/978-0-387-31416-7_2
|
| 26 |
Lucija Virović-Jukić, Jelena Forgač, Doris Ogresta, Tajana Filipec-Kanižaj, Anna Mrzljak. Gastrointestinal Complications of Diabetes. Clinical Gastroenterology 2018; : 275 doi: 10.1007/978-3-319-75856-5_21
|
| 27 |
J J Yu, F Shen, T H Chen, L Liang, J Han, H Xing, Y H Zhou, H Wang, W M Gu, W Y Lau, T Yang. Multicentre study of the prognostic impact of preoperative bodyweight on long-term prognosis of hepatocellular carcinoma. Journal of British Surgery 2019; 106(3): 276 doi: 10.1002/bjs.10981
|
| 28 |
S-N Wang, Y-T Yeh, S-F Yang, C-Y Chai, K-T Lee. Potential role of leptin expression in hepatocellular carcinoma. Journal of Clinical Pathology 2006; 59(9): 930 doi: 10.1136/jcp.2005.035477
|
| 29 |
Naoki Watanabe, Koji Takai, Kenji Imai, Masahito Shimizu, Takafumi Naiki, Masahito Nagaki, Hisataka Moriwaki. Increased levels of serum leptin are a risk factor for the recurrence of stage I/II hepatocellular carcinoma after curative treatment. Journal of Clinical Biochemistry and Nutrition 2011; 49(3): 153 doi: 10.3164/jcbn.10-149
|
| 30 |
Tahani Amer, Rizk El-Baz, Abdel-Rahman Mokhtar, Saad El-Shaer, Rami Elshazli, Ahmad Settin. Genetic polymorphisms of IL-23R (rs7517847) and LEP (rs7799039) among Egyptian patients with hepatocellular carcinoma. Archives of Physiology and Biochemistry 2017; 123(5): 279 doi: 10.1080/13813455.2017.1320680
|
| 31 |
Tohru Utsunomiya. Impact of obesity on the surgical outcome following repeat hepatic resection in Japanese patients with recurrent hepatocellular carcinoma. World Journal of Gastroenterology 2008; 14(10): 1553 doi: 10.3748/wjg.v14.i10.1553
|
| 32 |
Giammarco Fava, Gianfranco Alpini, Chiara Rychlicki, Stefania Saccomanno, Sharon DeMorrow, Luciano Trozzi, Cinzia Candelaresi, Julie Venter, Antonio Di Sario, Marco Marzioni, Italo Bearzi, Shannon Glaser, Domenico Alvaro, Luca Marucci, Heather Francis, Gianluca Svegliati-Baroni, Antonio Benedetti. Leptin Enhances Cholangiocarcinoma Cell Growth. Cancer Research 2008; 68(16): 6752 doi: 10.1158/0008-5472.CAN-07-6682
|